Steph & CO Bristol Myers Squibb CO Transaction History

Steph & CO

$255 Million
Q4 2024

A detailed history of Steph & CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Steph & CO holds 11,296 shares of BMY stock, worth $644,888. This represents 0.25% of its overall portfolio holdings.

Number of Shares

11,296

Previous 11,753 3.89%

Holding current value

$644,888

Previous $608,000 4.93%

% of portfolio

0.25%

Previous 0.22%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$51.92 - $59.94 $23,727 - $27,392	-457 Reduced 3.89%	11,296 $638,000
Q3 2024 Oct 15, 2024	BUY	$39.66 - $51.75 $10,390 - $13,558	262 Added 2.28%	11,753 $608,000
Q2 2024 Jul 30, 2024	BUY	$40.25 - $52.99 $1,368 - $1,801	34 Added 0.3%	11,491 $477,000
Q1 2024 Apr 12, 2024	BUY	$47.98 - $54.4 $138,134 - $156,617	2,879 Added 33.56%	11,457 $621,000
Q4 2023 Jan 31, 2024	SELL	$48.48 - $57.85 $124,642 - $148,732	-2,571 Reduced 23.06%	8,578 $440,000
Q3 2023 Oct 26, 2023	BUY	$57.89 - $64.73 $18,640 - $20,843	322 Added 2.97%	11,149 $647,000
Q2 2023 Jul 14, 2023	BUY	$63.71 - $70.74 $1,274 - $1,414	20 Added 0.19%	10,827 $692,000
Q1 2023 Apr 18, 2023	BUY	$65.71 - $74.53 $262 - $298	4 Added 0.04%	10,807 $749,000
Q4 2022 Jan 26, 2023	BUY	$68.48 - $81.09 $43,347 - $51,329	633 Added 6.22%	10,803 $777,000
Q3 2022 Oct 11, 2022	BUY	$0.13 - $76.84 $46 - $27,201	354 Added 3.61%	10,170 $723,000
Q2 2022 Jul 13, 2022	BUY	$72.62 - $79.98 $122,292 - $134,686	1,684 Added 20.71%	9,816 $756,000
Q1 2022 Apr 15, 2022	BUY	$61.48 - $73.72 $6,762 - $8,109	110 Added 1.37%	8,132 $594,000
Q4 2021 Jan 24, 2022	SELL	$53.63 - $62.52 $2,091 - $2,438	-39 Reduced 0.48%	8,022 $500,000
Q3 2021 Oct 22, 2021	BUY	$59.17 - $69.31 $43,489 - $50,942	735 Added 10.03%	8,061 $477,000
Q2 2021 Jul 27, 2021	BUY	$61.91 - $67.42 $97,879 - $106,591	1,581 Added 27.52%	7,326 $490,000
Q1 2021 Apr 16, 2021	SELL	$59.34 - $66.74 $3,797 - $4,271	-64 Reduced 1.1%	5,745 $363,000
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $84,589 - $95,854	1,465 Added 33.72%	5,809 $360,000
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $80,402 - $89,096	-1,400 Reduced 24.37%	4,344 $262,000
Q1 2020 Apr 14, 2020	SELL	$46.4 - $67.43 $35,588 - $51,718	-767 Reduced 11.78%	5,744 $320,000
Q4 2019 Feb 24, 2020	BUY	$49.21 - $64.19 $320,406 - $417,941	6,511 New	6,511 $418,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.46B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steph & CO, based on Form 13F filings with the SEC.

News

Stay updated on Steph & CO with notifications on news.

Account